Comparison of Early Complication Rates After High Tibial Osteotomy Versus Unicompartmental Knee Arthroplasty for Knee Osteoarthritis.

complications high tibial osteotomy osteoarthritis unicompartmental knee arthroplasty

Journal

Orthopaedic journal of sports medicine
ISSN: 2325-9671
Titre abrégé: Orthop J Sports Med
Pays: United States
ID NLM: 101620522

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 06 07 2023
accepted: 31 07 2023
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: epublish

Résumé

Although both high tibial osteotomy (HTO) and unicompartmental knee arthroplasty (UKA) can be utilized to treat unicompartmental osteoarthritis (OA) in select patients, the early complication rates between the 2 procedures are not well understood. Understanding of the complication profiles for both procedures would help clinicians counsel patients with unicompartmental knee OA who may be eligible for either treatment option. To compare the 30-day complication rates after HTO versus UKA for the treatment of knee OA using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database. Cohort study; Level of evidence, 3. NSQIP registries between 2006 and 2019 were queried using Current Procedural Terminology codes to identify patients undergoing HTO and UKA for knee OA. Patients >60 years of age were excluded. Patient demographics, preoperative comorbidities, and intraoperative data were collected. Postoperative 30-day complications, including venous thromboembolism (VTE), urinary tract infection (UTI), transfusion, surgical-site infection (SSI), and reoperations were recorded. Complication rates between treatment groups were compared using a multivariate logistic regression model adjusted for sex, age, body mass index, steroid use, respiratory status (smoking/dyspnea/chronic obstructive pulmonary disease), diabetes, and hypertension. A total of 156 patients treated with HTO and 4755 patients treated with UKA for knee OA were identified. Mean patient ages were 46 years for the HTO group and 53.4 years for the UKA group. Operative time was significantly longer in the HTO group versus the UKA group (112 minutes vs 90 minutes; There were no differences in 30-day VTE, UTI, transfusion, deep SSI, and reoperation rates for HTO versus UKA in the treatment of knee OA. HTO was associated with a higher rate of superficial SSI compared with UKA. These findings serve to guide clinicians in counseling patients regarding the early risks after HTO and UKA.

Sections du résumé

Background UNASSIGNED
Although both high tibial osteotomy (HTO) and unicompartmental knee arthroplasty (UKA) can be utilized to treat unicompartmental osteoarthritis (OA) in select patients, the early complication rates between the 2 procedures are not well understood. Understanding of the complication profiles for both procedures would help clinicians counsel patients with unicompartmental knee OA who may be eligible for either treatment option.
Purpose UNASSIGNED
To compare the 30-day complication rates after HTO versus UKA for the treatment of knee OA using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database.
Study Design UNASSIGNED
Cohort study; Level of evidence, 3.
Methods UNASSIGNED
NSQIP registries between 2006 and 2019 were queried using Current Procedural Terminology codes to identify patients undergoing HTO and UKA for knee OA. Patients >60 years of age were excluded. Patient demographics, preoperative comorbidities, and intraoperative data were collected. Postoperative 30-day complications, including venous thromboembolism (VTE), urinary tract infection (UTI), transfusion, surgical-site infection (SSI), and reoperations were recorded. Complication rates between treatment groups were compared using a multivariate logistic regression model adjusted for sex, age, body mass index, steroid use, respiratory status (smoking/dyspnea/chronic obstructive pulmonary disease), diabetes, and hypertension.
Results UNASSIGNED
A total of 156 patients treated with HTO and 4755 patients treated with UKA for knee OA were identified. Mean patient ages were 46 years for the HTO group and 53.4 years for the UKA group. Operative time was significantly longer in the HTO group versus the UKA group (112 minutes vs 90 minutes;
Conclusion UNASSIGNED
There were no differences in 30-day VTE, UTI, transfusion, deep SSI, and reoperation rates for HTO versus UKA in the treatment of knee OA. HTO was associated with a higher rate of superficial SSI compared with UKA. These findings serve to guide clinicians in counseling patients regarding the early risks after HTO and UKA.

Identifiants

pubmed: 38188617
doi: 10.1177/23259671231219975
pii: 10.1177_23259671231219975
pmc: PMC10768598
doi:

Types de publication

Journal Article

Langues

eng

Pagination

23259671231219975

Informations de copyright

© The Author(s) 2024.

Déclaration de conflit d'intérêts

One or more of the authors has declared the following potential conflict of interest or source of funding: D.W. has received a grant from Arthrex; education payments from Micromed, Arthrex, and Smith & Nephew; consulting fees from Medical Device Business Services, Vericel, DePuy Synthes Products, and Ipsen Bioscience; nonconsulting fees from Vericel; and hospitality payments from DePuy Synthes Sales, Saxum Surgical, Stryker, Ipsen Innovation, and Linvatec. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.

Auteurs

Theofilos Karasavvidis (T)

Department of Orthopaedic Surgery, University of California, Irvine, Orange, California, USA.
Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York, USA.

Nathan P Fackler (NP)

Department of Orthopaedic Surgery, University of California, Irvine, Orange, California, USA.
Department of Orthopaedic Surgery, University of California, San Diego, San Diego, California, USA.

Kylie T Callan (KT)

Department of Orthopaedic Surgery, University of California, Irvine, Orange, California, USA.

Brandon E Lung (BE)

Department of Orthopaedic Surgery, University of California, Irvine, Orange, California, USA.

Dean Wang (D)

Department of Orthopaedic Surgery, University of California, Irvine, Orange, California, USA.
Department of Biomedical Engineering, University of California, Irvine, Irvine, California, USA.

Classifications MeSH